LabCompass

Ken Mackie

Medicine · Indiana University

Publications

526

Citations

53,382

Est. group size

Recurring co-author estimate

Active years

44

Publishing since 1983

Research summary
AI-generated

Ken Mackie studies how cannabinoids (compounds related to cannabis, including cannabidiol/CBD and THC) and the body's own endocannabinoid system affect the brain and nervous system. His research examines cannabinoid receptors and related enzymes in relation to pain, stress, mood, and cognition, and increasingly overlaps with engineered brain organoids and devices that interface with neural tissue. The work sits at the intersection of pharmacology, neuroscience, and biomedical engineering.

Cannabinoid and endocannabinoid pharmacologyNeuropharmacology and receptor signalingNeuropathic pain and stress-related behaviorBrain organoids and neural-interface devicesCognition and behavioral neuroscience

Publication output has been steady at roughly 20 papers per year for most of the decade, with a somewhat lower count in the two most recent years.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 16.8/year recently
2017: 20 publications172018: 17 publications182019: 25 publications192020: 24 publications202021: 28 publications28212022: 19 publications222023: 19 publications232024: 20 publications242025: 13 publications252026: 13 publications26
Recent publications
Publishes in
  • bioRxiv (Cold Spring Harbor Laboratory)×25
  • Cannabis and Cannabinoid Research×9
  • Neuropharmacology×9
  • Pharmacological Research×8
  • Nature Communications×5

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile